Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Study of Vidutolimod (CMP-001) With Nivolumab in Patients With Metastatic Castration Resistant Prostate Cancer

NCT05445609 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05445609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05445609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Study of Vidutolimod (CMP-001) With Nivolumab in Patients With Metastatic Castration Resistant Prostate Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Suspended
Start date
June 7, 2023
Completion date
June 23, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate adenocarcinoma, stage iv prostate cancer ajcc v8